SCHEMBL9562369

SCHEMBL9562369

CCOC(=O)C(=CN(C)C)C(=O)c1cc(F)c(Cl)nc1Cl

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
CYP11B1 P15538 9/20 0.38
CYP11B2 P19099 8/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
CYP2C9 P11712 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
HPGD P15428 2/20 0.36
GAA P10253 1/20 0.34
ATM Q13315 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31696352 1.00 KEAP1 (0.44) KEAP1NFE2L2CYP11B1CYP11B2MEN1
SCHEMBL13756506 1.00 KEAP1 (0.44) KEAP1NFE2L2CYP11B1CYP11B2MEN1
SCHEMBL7237684 0.86 ATM (0.40) CYP11B1CYP11B2MEN1KMT2ACYP2C9
SCHEMBL7237682 0.86 ATM (0.40) CYP11B1CYP11B2MEN1KMT2ACYP2C9
SCHEMBL7012806 0.85 KEAP1 (0.47) KEAP1NFE2L2MEN1KMT2ACYP2C9
SCHEMBL14600962 0.85 KEAP1 (0.47) KEAP1NFE2L2MEN1KMT2ACYP2C9
SCHEMBL9775897 0.84 ATM (0.39) CYP11B1CYP11B2MEN1KMT2ACYP2C9
SCHEMBL9775894 0.84 ATM (0.39) CYP11B1CYP11B2MEN1KMT2ACYP2C9
SCHEMBL7229498 0.84 HPGD (0.35) CYP11B1CYP11B2MEN1KMT2ACYP2C9
SCHEMBL7229496 0.84 HPGD (0.35) CYP11B1CYP11B2MEN1KMT2ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4073062-B1 FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) RYVU THERAPEUTICS S A (PL) 2026-04-29 EP disclosed
EP-4073062-A1 FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-10-19 EP disclosed
EP-4073063-A1 HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-10-19 EP disclosed
CN-114787148-A Functionalized heterocyclic compounds as modulators of interferon gene Stimulators (STING) 雷沃医疗有限公司 2022-07-22 CN disclosed
CN-114787147-A Heterocyclic compounds as modulators of interferon gene Stimulators (STING) 雷沃医疗有限公司 2022-07-22 CN disclosed
CN-113950473-A Next generation modulators of interferon gene Stimulators (STING) 雷沃医疗有限公司 2022-01-18 CN disclosed
WO-2021116446-A1 FUNCTIONALIZED HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2021-06-17 WO disclosed
WO-2021116451-A1 HETEROCYCLIC COMPOUNDS AS MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2021-06-17 WO disclosed
US-5182401-A Bactericide intermediate BAYER AKTIENGESELLSCHAFT (DE) 1993-01-26 US disclosed